Synthesis, X-ray structure and antimicrobial activity of 6-(1,3-benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3H)-one (8) are reported. Compound 8 exhibited activity towards S. aureus with MIC value of 0.0619 mol/mL while it showed activity towards B. subtilis, B. cereus, C. albicans, and A. niger with MIC = 0.1859 mol/mL. Single crystal X-ray structure of the title compound 8 confirmed its S-alkylation. The title compound crystallizes in the triclinic, -1, = 11.1220 (5)Å, = 12.2241 (5)Å, = 21.5246 (9)Å, = 88.958 (2) ∘ , = 79.836 (2) ∘ , = 79.384 (2) ∘ , = 2830.9 (2)Å 3 , = 6, R( ) = 0.046, wR ( 2 ) = 0.110, = 100 K. The crystal structure is stabilized by weak intermolecular C-H⋅ ⋅ ⋅ O and N-H⋅ ⋅ ⋅ O hydrogen interactions.
Introduction
Pyrimidines are attractive scaffolds for drug design and development since their discovery as components of DNA and RNA. Besides, pyrimidines are incorporated in a plethora of bioactive molecules with various biological activities. The chemotherapeutic effect of pyrimidines could be attributed to their ability to inhibit vital enzymes responsible for the nucleic acid biosynthesis. Several pyrimidines showed antiviral [1] [2] [3] , antimicrobial [4] [5] [6] [7] [8] , anticancer [9] [10] [11] , antiinflammatory [12, 13] , antileishmanial [14, 15] , and cardiovascular activities [16, 17] .
On the other hand, a sizable number of bioactive molecules bearing 1,3-benzodioxole moiety exhibited multiple biological activities like antioxidant [18, 19] , anticancer [20, 21] , anti-inflammatory [22, 23] , anticonvulsant [24] , antihypertensive [25] , antidepressant [26] , immunomodulators [27] , and antiprotozoal [28, 29] .
In continuation of our ongoing research on the synthesis of potential antimicrobial pyrimidinones [30] , we report herein the synthesis, single crystal X-ray structure, and antimicrobial activity of new pyrimidinone derivative incorporating 1,3-benzodioxole moiety, namely, 6-(1,3-benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3H)-one.
gel TLC (thin layer chromatography) plates from Merck (silica gel precoated aluminium plates with fluorescent indicator at 254 nm) were used for thin layer chromatography. Visualization was performed by illumination with UV light source (254 nm). Compound 4 was prepared according to the reported literature procedures [31] [32] [33] . The tested microorganisms (Gram-positive bacteria, Staphylococcus aureus ATCC 29213, Bacillus subtilis NRRL 4219, and Bacillus cereus; pathogenic fungi, Candida albicans ATCC 10231 and Aspergillus niger NRRL 599) were obtained from MIRCIN Cairo, Faculty of Agriculture, Ain Shams University, Cairo, Egypt. The reference drugs ampicillin trihydrate (CAS 7177-48-2) and clotrimazole (CAS 23593-75-1) were obtained from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). The X-ray diffraction measurements of compound 8 were performed using Bruker Venture D8 diffractometer.
Synthesis of 6-(1,3-Benzodioxol-5-ylmethyl)-5-ethyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (7).
A suspension of activated zinc dust [30] (7 g) in dry THF (30 mL) was heated to reflux. Few drops of ethyl 2-bromobutanoate (5) were added and the reaction mixture was refluxed for 10 min. The piperonylcarbonitrile (4) (2.42 g, 0.015 mol) was added in one portion while the rest of ester 5 (5.85 g, 0.03 mol) was added dropwise. After complete addition, the reaction mixture was refluxed for 30 min, then diluted with THF (100 mL), and quenched by addition of sat. aq. K 2 CO 3 solution (30 mL). The reaction mixture was stirred for 1 h at room temperature and then the THF layer was removed and the residue was washed with THF (3 × 20 mL). The combined THF fractions were stirred with 10% aq. HCl (20 mL) for 30 min. The solution was concentrated under reduced pressure and diluted with CH 2 Cl 2 (100 mL). The organic phase was washed with sat. aq. NaHCO 3 solution (2 × 50 mL), dried (Na 2 SO 4 ), and evaporated under reduced pressure to give the respective -ketoester 6 as a pale yellow viscous oil. The crudeketoester 6 (2.78 g, 0.01 mol) was added to a boiling solution of sodium ethoxide (prepared from 4.9 g of Na in 100 mL of absolute EtOH) containing thiourea (11.42 g, 0.15 mol). The reaction mixture was heated to reflux for 24 h. The solvent was evaporated to dryness under reduced pressure and the residue was dissolved in H 2 O (100 mL). The product was precipitated by addition of conc. HCl till pH = 4. The precipitate was filtered off, washed with H 2 O, and dried to give the corresponding thiouracil derivative 7. The crude 7 was purified by recrystallization (ethanol) to afford pure 7 in 46% yield as a white solid mp 183-185 ∘ C. Cell refinement and data reduction were done by Bruker SAINT [34] ; program used to solve structure and refine structure is SHELXTL [35] . The final refinement was performed by full-matrix least-squares techniques with anisotropic thermal data for non hydrogen atoms on 2 . All the hydrogen atoms were placed in calculated positions and constrained to ride on their parent atoms. Multiscan absorption correction was applied by use of SADABS software [34] . The crystallographic data and refinement information are summarized in Table 1 .
Antimicrobial Activity by the Agar Disc-Diffusion Method.
Sterile nutrient, malt extract, and Czapek's dox agar media were inoculated, separately, with 100 L cell suspension of the chosen bacteria, Candida albicans, and Aspergillus niger, respectively, and poured into Petri dishes (20 cm diameter). The test compound 8 (200 g/10 mm diameter disc) was placed onto the surface of the agar Petri dishes. The antimicrobial potential was expressed as the diameter of the growth inhibition zone in mm [36] .
Minimum Inhibitory Concentrations (MICs).
The minimum inhibitory concentration (MIC) of the test compound 8 was evaluated using serial dilutions technique [37] . Different concentrations ranging from 50 to 200.0 g for the test compound 8 were dissolved in dimethyl sulfoxide (1 mL) and were placed on filter paper disc (1 cm diameter). The discs were deposited on the surface of inoculated agar plates and kept at low temperature before incubation which favours diffusion over microbial growth to detect the inhibition zone clearly. The plates were incubated at 30 ∘ C for 24 h for bacteria and Candida albicans and for 48 h for Aspergillus niger.
Results and Discussion

Chemistry.
The commercially available piperonal (1) was elaborated to piperonylcarbonitrile (4) as portrayed in Scheme 1. Thus, piperonal (1) was reduced with sodium borohydride in methanol at room temperature to give the piperonyl alcohol (2) [31] in almost quantitative yield. The alcohol 2 was allowed to react with thionyl chloride to give the chloro derivative 3 [32] . Subsequently, compound 3 was subjected to nucleophilic substitution using sodium cyanide and a catalytic amount of potassium iodide in dimethylformamide to yield the respective piperonylcarbonitrile (4) [33] in about 75% overall yield.
Scheme 2 illustrates the synthetic pathway to achieve the target compound 8 and its intermediates. was allowed to react with ethyl 2-bromobutanoate (5) in dry tetrahydrofuran in the presence of zinc dust under Reformatsky conditions [38] to furnish ethyl 4-(1,3-benzodioxol-5-yl)-2-ethyl-3-oxobutanoate (6) in good yield. Reaction of thiourea with the crude -ketoester 6 in absolute ethanol in the presence of sodium ethoxide gave the pivotal 6-(1,3-benzodioxol-5-ylmethyl)-5-ethyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (7) in 46% yield. Thiouracil 7 was reacted with N-(2-chloroethyl) morpholine hydrochloride in the presence of anhydrous potassium carbonate in dimethylformamide at room temperature to afford the title compound 6-(1,3-benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl} pyrimidin-4(3H)-one (8) in 58% yield. Single crystal X-ray crystallography confirmed the 3D structure of compound 8.
Crystal Structure of Compound 8.
Single crystal X-ray crystallography is a doubtlessly decisive analytical tool which can confirm the 3D structure of the target compound 8, particularly its S-alkylation. Fortunately, we have succeeded to get single crystals of compound 8 which were suitable for X-ray crystallography (Figure 1) .
The asymmetric unit contains three molecules of the title compound 8. The molecular packing in the crystal structure is stabilized by the weak intermolecular interactions ( Figure 2, Table 2 ), of which O3B, O2A, and O4B work as acceptor while N2B, C3A, and C19B work as donors.
The distance H1NB⋅ ⋅ ⋅ O3B is 1.87 (2)Å, H3AB⋅ ⋅ ⋅ O2A is 2.5300, and H19D⋅ ⋅ ⋅ O4B is 2.5600Å, and the angles between N2B-H1NB⋅ ⋅ ⋅ O3B, C3A-H3AB⋅ ⋅ ⋅ O2A, and C19B-H19D⋅ ⋅ ⋅ O4B are 173 (2), 146.00 (2), and 140.00 ∘ (2), respectively. There are four intramolecular H-bonds in the molecules: in the first molecule, there is one H-bond between C16A-H16B⋅ ⋅ ⋅ N1A; in the second molecule, there is one Hbond between C15B-H15C⋅ ⋅ ⋅ N1B; and in the third molecule, there are two H-bonds between C16C-H16E⋅ ⋅ ⋅ N1C and C17C-H17F⋅ ⋅ ⋅ O1C. The selected bond lengths, bond angles, and bond torsion angles are listed in Table 3 . The preliminary antimicrobial potential of the test compound 8 was evaluated using DIZ assay and the results are given in Table 4 Table 2 : Hydrogen-bond geometry (Å, ∘ ). 
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